Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery and real world evidence pipeline utilizing the next generation artificial intelligence, will present its research and introduce the "Cure a disease in a year" program at the World's leading congress for big data in precision medicine - Biodata World Congress 2018.
Biodata World 2018 is the world's leading conference focused on big data and precision medicine. It brings together new methods in data discovery and generation, applications of AI and machine learning. The congress will take place at Congress Center Basel, 28-29 November 2018.
"Our company published the many proofs of concept for the applications of modern AI in drug discovery and completed many pilots. However, the pharmaceutical industry is not moving fast enough. Several pharmaceutical companies are claiming to have hundreds of data scientists and the many petabytes of legacy data that will help them turn into the data companies. But so far with no tangible results coming out of these efforts. It is time to unveil our end-to-end drug discovery pipeline and offer rare disease foundations a chance to collect the data required for this pipeline and get the targets and molecules for testing. For the first time we will present our "Cure a disease in a year" program at Biodata World Congress 2018, which gathers the key opinion leaders from the academia and industry.", saids Alex Zhavoronkov, PhD, Founder, and CEO of Insilico Medicine, Inc.
"Artificial Intelligence (AI) techniques, such as deep learning (DL), reinforcement learning (RL), and generative adversarial networks (GANs) play a pivotal role in studying the biology of aging on many levels. We are excited to share our vision and latest results at the industry's leading event for Data and AI in healthcare", - said Alex Zhebrak, CTO of Insilico Medicine, Inc.
According to the Chair of "AI in Ageing Research and Longevity" Round Table, Tina Woods, Founder of Collider Health: "This is an exciting time in health and longevity. Insights can be gathered from DNA and other health, behavioral and environmental information with astonishing efficiency using AI- and all this can drive 'smarter' research and more personalized strategies to increase our 'healthspan'. I hope one day we can each have our own 'Life Dashboard' giving us the power to leverage our genetic, health, wealth and life data, and nudging us in the right ways to live a longer, healthier life while helping billions of others too".
Diabetes drugs cut asthma attacks by up to 70%, reshaping treatment options